The world of medication-assisted treatment recently saw the arrival of a promising, first-of-its-kind new way to help patients battle long-term opioid dependency. Probuphine was approved by the FDA in May of 2016 and is the first and only six-month buprenorphine implant. The device goes into patients’ arms and helps reduce cravings and withdrawal symptoms. It is being hailed in many clinical circles as a potential gamechanger in ongoing opioid addiction treatment. Like other opioid maintenance medications, including Vivitrol, Suboxone and methadone, it is not meant to replace any element of treatment; but rather occur alongside established care practices, like group dynamics and individualized psychotherapy.
While Probuphine has been readily available for a year, it is only recently become a fixture in clinical treatment. As is the case with all maintenance medications, there is a variety of physical and psychological side effects associated with use of the drug, including but not limited to:
- Back Pain
- Tooth Pain
- And More
If you or a loved one are experiencing these or any other peculiar symptoms related to your use of the Probuphine talk to your prescribing physician immediately. Patients should not attempt to remove or adjust their implant without the help of an experienced and qualified expert.
Eligibility for Probuphine treatment will vary according to each user’s care needs and medical history. The drug may be ideal for:
- Patients 16 Years of Age or Older Suffering from Opioid Addiction
- Patients Who Don’t Want to Take a Medication Every Day for Opioid Cravings
- Patients Taking 8 Milligrams or Less of Buprenorphine
- Patients Who Are Vulnerable to Suboxone Abuse
- And More
Talk to your doctor or treatment professional to determine if Probuphine is right for you or your loved one. It’s important to realize that all medications come with their own special set of risks and rewards.